id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-D-1005-0016,FDA,FDA-2012-D-1005,"Safety Considerations for Product Design to Minimize Medication Errors
Guidance for Industry",Other,Guidance,2016-04-12T04:00:00Z,2016,4,2016-04-12T04:00:00Z,,2024-11-07T23:44:14Z,,1,0,0900006481f616d6
FDA-2012-D-1005-0015,FDA,FDA-2012-D-1005,"Safety Considerations for Product Design To Minimize Medication Errors;
Guidance for Industry; Availability",Notice,Notice of Availability,2016-04-12T04:00:00Z,2016,4,2016-04-12T04:00:00Z,,2016-04-12T13:30:02Z,2016-08335,0,0,0900006481f60c32
FDA-2012-D-1005-0001,FDA,FDA-2012-D-1005,Draft Guidances for Industry on Safety Considerations for Product Design to Minimize Medication Errors; Availability,Notice,Notice of Availability,2012-12-13T05:00:00Z,2012,12,2012-12-13T05:00:00Z,2013-02-12T04:59:59Z,2013-02-12T03:01:51Z,2012-30034,0,0,090000648118af95
FDA-2012-D-1005-0002,FDA,FDA-2012-D-1005,Safety Considerations for Product Design to Minimize Medication Errors - Draft Guidance,Other,Guidance,2012-12-13T05:00:00Z,2012,12,2012-12-13T05:00:00Z,,2024-11-12T05:11:44Z,,1,0,090000648118b81d